Showing results (341-350 of 457) with videos related to
Sort By:
Pageof 46
Rheumatology and Therapy|November 20, 2020
Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM StudyPascal Hilliquin, Thomas Barnetche, Athan Baillet, et al.Frontiers in Physiology|August 16, 2021
Insulin Resistance and Type 2 Diabetes in Asymptomatic Obstructive Sleep Apnea: Results of the PROOF Cohort Study After 7 Years of Follow-UpLaurine Vacelet, David Hupin, Vincent Pichot, et al.International Journal of Otolaryngology|November 3, 2011
The lyon clinical olfactory test: validation and measurement of hyposmia and anosmia in healthy and diseased populationsCatherine Rouby, Thierry Thomas-Danguin, Michel Vigouroux, et al.Journal of Vascular and Interventional Radiology : JVIR|May 22, 2026
« Combination of Percutaneous Cryoablation, Screw Fixation, and Cementoplasty for Painful Pelvic Bone Metastases: A Supportive Care Approach Improving Pain, Mobility, and Quality of Life»Sylvain Grange, Rémi Grange, Nicolas Stacoffe, et al.The Journal of Clinical Endocrinology and Metabolism|October 25, 2007
Constitutional thinness: unusual human phenotype of low bone qualityBogdan Galusca, Mohamed Zouch, Natacha Germain, et al.Seminars in Arthritis and Rheumatism|April 10, 2020
Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practiceAmbre Lauret, Anna Moltó, Vered Abitbol, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 8, 2004
Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS StudyClaus C Glüer, Richard Eastell, David M Reid, et al.Lancet (London, England)|April 14, 2009
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trialDavid M Reid, Jean-Pierre Devogelaer, Kenneth Saag, et al.Frontiers in Cell and Developmental Biology|October 19, 2020
Development of Enthesopathies and Joint Structural Damage in a Murine Model of X-Linked HypophosphatemiaCarole-Anne Faraji-Bellée, Axelle Cauliez, Benjamin Salmon, et al.The Journal of Clinical Endocrinology and Metabolism|January 23, 2014
Oxytocin, a new determinant of bone mineral density in post-menopausal women: analysis of the OPUS cohortVéronique Breuil, Patricia Panaia-Ferrari, Eric Fontas, et al.Pageof 46